EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antithrombotic and Lipid Lowering Therapy is Associated With Improved Survival After Vascular Surgery: A Population Based Study From Norway

Martin Altreuther, Arne Seternes, Turi Saltnes, Nadia Myrbø, Kristin Vikan, Linn Hege Nilsen, Tingting Feng

European Journal of Vascular and Endovascular Surgery · 2024

DOI: 10.1016/j.ejvs.2023.10.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2024. Verfasst von Martin Altreuther und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Vascular Surgery, Department of Surgery, Trondheim University Hospital, St Olavs Hospital, Trondheim, Norway; Department of Circulation an…. Hauptthemen laut MEDLINE: Vascular Surgical Procedures, Registries, Aortic Aneurysm, Abdominal, Carotid Stenosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This population based retrospective cohort study aimed to investigate the association between combined treatment with lipid lowering drugs and antiplatelet or anticoagulation therapy and long term survival following vascular surgery in Norway. METHODS: The study included all patients who were registered for the treatment of carotid stenosis, abdominal aortic aneurysm (AAA), and atherosclerotic lower extremity arterial disease (LEAD) in the Norwegian Registry for Vascular Surgery between 2015 and 2019 and who were discharged alive. Clinical and medication details were retrieved from the register. Survival was assessed with Kaplan-Meier analysis and a multivariable Cox regression model. Stratification was according to treatment group, patient sex, and if patients received the recommended medications or not. Recommended medications were defined as lipid lowering drugs, usually statins, and antiplatelets, or sometimes anticoagulants, when comorbidity indicated anticoagulation therapy. RESULTS: In total, 15 810 patients had LEAD, 4 080 patients AAA, and 2 194 patients had carotid stenosis. In all treatment groups, survival was superior for patients who used the recommended medications upon discharge. The difference was greatest in patients with LEAD with mean survival periods of 4.33 (95% CI 4.29 - 4.36) and 3.7 (95% CI 3.64 - 3.77) years in patients discharged with and without the recommended medications, respectively (p < .001). The mean survival periods were 4.67 (95% CI 4.61 - 4.73) and 4.34 (95% CI 4.24 - 4.44) years in patients with AAA discharged with and without the recommended medications, respectively (p < .001). Cox regression analysis showed a statistically significantly lower mortality rate for patients discharged with the recommended medications for LEAD (HR 0.58; p < .001) and AAA (HR 0.57; p < .001). CONCLUSION: The recommended medications were associated with improved survival in all treatment groups and both sexes. The survival difference was statistically significant in patients with LEAD and AAA. Patients with LEAD had the greatest improvement; therefore, the recommended secondary prophylaxis is especially important in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Surgical ProceduresRegistriesAortic Aneurysm, AbdominalCarotid StenosisHumansMaleFemaleAgedNorwayRetrospective StudiesAged, 80 and overMiddle AgedFibrinolytic AgentsPlatelet Aggregation InhibitorsHypolipidemic AgentsPeripheral Arterial DiseaseRisk FactorsTreatment OutcomeAnticoagulantsDrug Therapy, CombinationHydroxymethylglutaryl-CoA Reductase Inhibitors

Stichwörter der Autor:innen

Abdominal aortic aneurysmCarotid and peripheral arterial diseaseKaplan–Meier survivalProphylaxis

Substanzen

Fibrinolytic AgentsPlatelet Aggregation InhibitorsHypolipidemic AgentsAnticoagulantsHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Section of Vascular Surgery, Department of Surgery, Trondheim University Hospital, St Olavs Hospital, Trondheim, Norway; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Tro…
  • Norwegian Registry for Vascular surgery (NORKAR), Department of Medical Quality Registries, St Olavs hospital, Trondheim University Hospital, Trondheim, Norway.

Zitieren

APA

Altreuther, M., Seternes, A., Saltnes, T., Myrbø, N., Vikan, K., Nilsen, L. H., & Feng, T. (2024). Antithrombotic and Lipid Lowering Therapy is Associated With Improved Survival After Vascular Surgery: A Population Based Study From Norway. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2023.10.019

Vancouver

Altreuther M, Seternes A, Saltnes T, Myrbø N, Vikan K, Nilsen LH, et al. Antithrombotic and Lipid Lowering Therapy is Associated With Improved Survival After Vascular Surgery: A Population Based Study From Norway. European Journal of Vascular and Endovascular Surgery. 2024. doi:10.1016/j.ejvs.2023.10.019

BibTeX
@article{Altreuther2024,
  author = {Altreuther, Martin and Seternes, Arne and Saltnes, Turi and Myrbø, Nadia and Vikan, Kristin and Nilsen, Linn Hege and Feng, Tingting},
  title = {Antithrombotic and Lipid Lowering Therapy is Associated With Improved Survival After Vascular Surgery: A Population Based Study From Norway},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2024},
  doi = {10.1016/j.ejvs.2023.10.019}
}
Kostenlos starten →